These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22175133)

  • 1. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 5. Leflunomide and mizoribine].
    Sawada T
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2929-35. PubMed ID: 22175133
    [No Abstract]   [Full Text] [Related]  

  • 2. An unusual overdose of leflunomide in a patient with rheumatoid arthritis.
    Kamali S; Kasapoglu E; Uysal M; Inanc M; Gul A
    Ann Pharmacother; 2004; 38(7-8):1320-1. PubMed ID: 15138298
    [No Abstract]   [Full Text] [Related]  

  • 3. Leflunomide.
    Cohen SB; Iqbal I
    Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R
    Lancet; 1999 Jan; 353(9149):259-66. PubMed ID: 9929017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis and the Arava (leflunomide) controversy.
    Turkoski BB
    Orthop Nurs; 2003; 22(1):48-51. PubMed ID: 12640952
    [No Abstract]   [Full Text] [Related]  

  • 7. The broadening use of leflunomide in clinical practice.
    Kiely PD
    Hosp Med; 2004 Dec; 65(12):735-9. PubMed ID: 15624449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 9. [Leflunomide (Arava) in the treatment of rheumatoid arthritis].
    Kaliterna DM
    Reumatizam; 2007; 54(2):67-8. PubMed ID: 18351143
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
    Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide-associated progressive multifocal leukoencephalopathy.
    Rahmlow M; Shuster EA; Dominik J; Deen HG; Dickson DW; Aksamit AJ; Robles HA; Freeman WD
    Arch Neurol; 2008 Nov; 65(11):1538-9. PubMed ID: 19001176
    [No Abstract]   [Full Text] [Related]  

  • 12. Newer immunomodulating drugs in rheumatoid arthritis may precipitate glomerulonephritis.
    Kemp E; Nielsen H; Petersen LJ; Gam AN; Dahlager J; Horn T; Larsen S; Olsen S
    Clin Nephrol; 2001 Jan; 55(1):87-8. PubMed ID: 11200876
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of leflunomide in active rheumatoid arthritis.
    Smolen JS; Emery P
    Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():48-56. PubMed ID: 11001380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe liver damage with leflunomide.
    Prescrire Int; 2001 Oct; 10(55):149. PubMed ID: 11824431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of dermatomyositis in a woman with rheumatoid arthritis treated with leflunomide].
    Gómez Rodríguez N; Zulaica Garate A
    An Med Interna; 2005 Jun; 22(6):300-1. PubMed ID: 16145732
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritis.
    Ichinose K; Origuchi T; Kawashiri SY; Iwamoto N; Fujikawa K; Aramaki T; Kamachi M; Arima K; Tamai M; Nakamura H; Ida H; Kawakami A; Tsukada T; Ueki Y; Eguchi K
    Intern Med; 2010; 49(20):2211-8. PubMed ID: 20962439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis.
    Kawai S; Hashimoto H; Kondo H; Murayama T; Kiuchi T; Abe T
    J Rheumatol; 2006 Nov; 33(11):2153-61. PubMed ID: 16960930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide in dermatology.
    Boyd AS
    J Am Acad Dermatol; 2012 Apr; 66(4):673-9. PubMed ID: 21962758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin ulceration after leflunomide treatment in two patients with rheumatoid arthritis].
    Jakob A; Porstmann R; Rompel R
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):324-7. PubMed ID: 16638062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.